While anti-LAG-3 has shown little effect as monotherapy, dual anti-LAG-3/anti-PD-1 treatment exerted potent anti-tumor effects in mice with melanoma and colon carcinoma [80]. This evidence concerns the gene LAG3 and neoplasm.